Niosomes with sorbitan monoester as a carrier for vaginal delivery of insulin: Studies in rats

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 12, Issue 6, 2005, Pages 399-407

  Ning, Meiying ^a,b   Guo, Yingzhi ^b   Pan, Huaizhong ^b   Yu, Heming ^b   Gu, Zhongwei ^b  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

Author keywords

Insulin; Niosomes; Vaginal Delivery

Indexed keywords

DRUG CARRIER; INSULIN; NIOSOME; SORBITAN; SORBITAN ESTER; SORBITAN PALMITATE; SORBITAN STEARATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; ENCAPSULATION; EVAPORATION; FEMALE; HYPOGLYCEMIA; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; ULTRASOUND;

ADMINISTRATION, INTRAVAGINAL; ALLOXAN; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; FEMALE; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; OVARIECTOMY; PARTICLE SIZE; POLYSORBATES; RATS; RATS, WISTAR; SOLUBILITY;

EID: 27644512131     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540590968891     Document Type: Article

References (27)

1. Agarwal, R., Katare, O. P., and Vyas, S. P. 2001. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int. J. Pharm. 228:43-52.
2. Chattaraj, S. C., and Das, S. K. 2003. Physicochemical characterization of influenza viral vaccine loaded surfactant vesicles. Drug Deliv. 10:73-77.
3. Corbo, D. C., and Liu, J. C. 1990. Characterization of the barrier properties of mucosal membranes. J. Pharm. Sci. 79(3):202-207.
4. Fang, J. Y., Hong, C. T., and Chiu, W. T. 2001. Effect of liposomes and niosomes on skin permeation of enoxacin. Int. J. Pharm. 219:61-72.
5. Jerry, N., and Anitha, Y. 2001. In vivo absorption studies of insulin from an oral delivery system. Drug Deliv. 8:19-23.
6. Khaksa, G., D'Souza, R., Lewis S., et al. 2000. Pharmacokinetic study of niosome encapsulated insulin. Ind. J. Exp. Bio. 38:901-905.
7. Kisel, M. A., Kulik, I. N., and Tsybovsky, I. S. 2001. Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat. Int. J. Pharm. 216:105-114.
8. Manconi, M., Sinico, C., and Valenti, D. 2002. Niosomes as carriers for tretionoin. 1. Preparation and properties. Int. J. Pharm. 234:237-248.
9. Morimoto, K., Takeeda, T., and Nakamoto, Y. 1982. Effective vaginal absorption of insulin in diabetic rats and rabbits using polyacrylic acid aqueous gel bases. Int. J. Pharm. 12:107-111.
10. Morishita, M., Sinico, C., Valenti, D., et al. 1992. Novel oral microspheres of insulin with protease inhibitor protecting from enzymatic degradation. Int. J. Pharm. 78:1-7.
11. Naresh, R. A. R., and Udupa, N. 1996. Niosome encapsulated bleomycin. STP Pharm. Sci. 6:61-71.
12. Owens, D. R., Zinman, B., and Bolli, G. 2003. Alternative routes of insulin delivery. Diabetic Med. 20:886-898.
13. Parthasarathi, G., Udupa, N., Umadevi, P., et al. 1994. Niosome encapsulated of vincristine sulfate-improved anticancer activity with reduced toxicity in mice. J. Drug Target. 2:173-182.
14. Reddy, D. N., and Udupa, N. 1993. Formulation and evaluation of oral and transdermal preparations of flurbiprofen and piroxicam incorporated with different carriers. Drug Dev. Ind. Pharm. 19:843-852.
15. Rentel, C.-O., Bouwstra, J. A., and Naisbett, B. 1999. Niosomes as a novel peroral vaccine delivery system. Int. J. Pharm. 186:161-167.
16. Richardson, J. L., and Ilium, L. 1992. Routes of delivery: case studies: the vaginal route of peptide and protein drug delivery. Adv. Drug Del. Rev. (8):341-366.
17. Richardson, J. L., Ilium, L., and Thomas, N. W. 1992. Vaginal absorption of insulin in the rat: effect of penetration enhancers on insulin uptake and mucosal histology. Pharma. Res. 9(7):878-883.
18. Richardson, J. L., Minhas, P. S., Thomas, N. W., and Ilium, L. 1989. Vaginal administration of gentamicin to rats. Pharmaceutical and morphological studies using absorption enhancers. Int. J. Pharm. 56:29-35.
19. Richardson, J. L., Ramires, P. A., and Miglietta, M. R. 1995. Novel vaginal delivery systems for calcitonin: I. Evaluation of HYAFF/calcitonin microspheres in rats. Int. J. Pharm. 115:9-15.
20. Schreier, H., and Bouwstra, J. 1994. Liposomes and niosomes as drug carriers: dermal and transdermal drug delivery. J. Control. Rel. 30:1-15.
21. Touitou, E., Donbrow, M., and Azaz, E. 1978. A new hydrophilic vehicle enabling rectal and vaginal absorption of insulin, heparin, phenol red and gentamicin. J. Pharm. Pharmacol. 30:662-663.
22. Touitou, E., Junginger, H. E., and Weiner, N. D. 1994. Liposomes as carriers for topical and transdermal delivery. J. Pharm. Sci. 83:1189-1203.
23. Uchegbu, I. F., Double, J. A., Turton, J. A., and Florence A. T. 1995. Distribution, metabolism and tumoricidal activity of duxorubicin administered in sorbitan monostearate (Span-60) niosomes in tile mouse. Pharm. Res. 12:1019-1024.
24. Uchegbu, I. F., and Vyas, S. P. 1998. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int. J. Pharm. 172:33-70.
25. Varshosaz, J., Pardakhty, A., Hajhashemi, V. I., and Najafabadi, A. R. 2003. Development and physical characterization of sorbitan monoester niosomes for insulin oral delivery. Drug Deliv. 10:251-262.
26. Yoshida, H., Lehr, C.-M., and Kok, W. 1992. Niosomes for oral delivery of peptide drugs. J. Control. Rel. 21:145-154.
27. Yoshika, T, Sternberg, B. and Florence, A. T. 1994. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, Span 40, Span 60 and Span 80) and a sorbitan trimester (Span 85). Int. J. Pharm. 105:1-6.